BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

933 related articles for article (PubMed ID: 18925580)

  • 21. Prenatal ultrasound findings in complete trisomy 9.
    Sepulveda W; Wimalasundera RC; Taylor MJ; Blunt S; Be C; De La Fuente S
    Ultrasound Obstet Gynecol; 2003 Nov; 22(5):479-83. PubMed ID: 14618660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation between increased fetal nuchal translucency thickness and chromosomal defects.
    Kagan KO; Avgidou K; Molina FS; Gajewska K; Nicolaides KH
    Obstet Gynecol; 2006 Jan; 107(1):6-10. PubMed ID: 16394033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebro-fronto-facial syndrome (Dandy-Walker Variant and frontofacial dysmorphisms): report of the first case identified by increased nuchal translucency beyond 13(+6) weeks.
    Tonni G; Azzoni D; Ambrosetti F; de Felice C; Ventura A
    Congenit Anom (Kyoto); 2007 Jun; 47(2):68-71. PubMed ID: 17504390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ultrasound soft markers and fetal cardiac structural assessment at 11-14 weeks].
    Yang Y; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):188-92. PubMed ID: 24820303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Value of nuchal translucency thickening in the fetal chromosome abnormality screening].
    Sun LJ; Wang X; Wu QQ; Ruan Y; Yao L
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):819-23. PubMed ID: 24444557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second-trimester prenatal screening for trisomy 21 using biochemical markers: a 7-year experience in one cytogenetic laboratory.
    Marical H; Douet-Guilbert N; Bages K; Collet M; Le Bris MJ; Morel F; De Braekeleer M
    Prenat Diagn; 2006 Apr; 26(4):308-12. PubMed ID: 16491510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
    Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
    Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype.
    Leung TY; Vogel I; Lau TK; Chong W; Hyett JA; Petersen OB; Choy KW
    Ultrasound Obstet Gynecol; 2011 Sep; 38(3):314-9. PubMed ID: 21400624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry.
    Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL
    Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Examination of fetal developmental abnormalities by routine transvaginal ultrasonic screening in the 12th week of pregnancy].
    Hernádi L; Töröcsik M; Pláyerné Dorkó A
    Orv Hetil; 1994 Jul; 135(28):1521-6. PubMed ID: 8058293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of 12-13-week scan for early diagnosis of fetal congenital anomalies in the cell-free DNA era.
    Kenkhuis MJA; Bakker M; Bardi F; Fontanella F; Bakker MK; Fleurke-Rozema JH; Bilardo CM
    Ultrasound Obstet Gynecol; 2018 Apr; 51(4):463-469. PubMed ID: 28397377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased nuchal translucency with normal karyotype: a follow-up study of 100 cases supplemented with CGH and MLPA analyses.
    Schou KV; Kirchhoff M; Nygaard U; Jørgensen C; Sundberg K
    Ultrasound Obstet Gynecol; 2009 Dec; 34(6):618-22. PubMed ID: 19953565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. First-trimester nuchal translucency measurement and echocardiography at 16 to 18 weeks of gestation in prenatal detection for trisomy 18.
    Cheng PJ; Liu CM; Chueh HY; Lin CM; Soong YK
    Prenat Diagn; 2003 Mar; 23(3):248-51. PubMed ID: 12627429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuchal translucency and nasal bone for trisomy 21 screening: single center experience.
    Monni G; Zoppi MA; Ibba RM; Floris M; Manca F; Axiana C
    Croat Med J; 2005 Oct; 46(5):786-91. PubMed ID: 16158472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?
    Comstock CH; Malone FD; Ball RH; Nyberg DA; Saade GR; Berkowitz RL; Ferreira J; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Bianchi DW; D'Alton ME;
    Am J Obstet Gynecol; 2006 Sep; 195(3):843-7. PubMed ID: 16949423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-trimester ductus venosus, nasal bones, and Down syndrome in a high-risk population.
    Prefumo F; Sethna F; Sairam S; Bhide A; Thilaganathan B
    Obstet Gynecol; 2005 Jun; 105(6):1348-54. PubMed ID: 15932828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [First trimester ultrasound screening for structural and chromosomal anomalies in multiple pregnancy].
    Markov D; Chernev T; Dimitrova V; Masneĭkova V; Leroy Y; Jacquemyn Y; Ramaekers P; Van Bulck B; Loquet P
    Akush Ginekol (Sofiia); 2004; 43(5):11-8. PubMed ID: 15518278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of increased nuchal translucency as a screening test for the detection of fetal chromosomal abnormalities.
    Alexioy E; Alexioy E; Trakakis E; Kassanos D; Farmakidis G; Kondylios A; Laggas D; Salamalekis E; Florentin L; Kanavakis E; Basios G; Trompoukis P; Georgiadoy L; Panagiotopoulos T
    J Matern Fetal Neonatal Med; 2009 Oct; 22(10):857-62. PubMed ID: 19521928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Results of cytogenetic examinations in fetuses with increased nuchal translucency].
    Kornacki J; Ziółkowska K; Goździewicz T; Skrzypczak J
    Ginekol Pol; 2012 Mar; 83(3):189-93. PubMed ID: 22568194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.